14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TVTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Travere Therapeutics, Inc. stock price on Tuesday moving between $6.74 and $7.69
(Updated on May 07, 2024)

Hold candidate since May 06, 2024 Gain 3.05% PDF

The Travere Therapeutics, Inc. stock price gained 3.05% on the last trading day (Tuesday, 7th May 2024), rising from $6.55 to $6.75. It has now gained 7 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 14.09% from a day low at $6.74 to a day high of $7.69. The price has risen in 7 of the last 10 days and is up by 17.6% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 553 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $12.77 million.

Given the current short-term trend, the stock is expected to fall -30.96% during the next 3 months and, with a 90% probability hold a price between $3.39 and $4.66 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TVTX Signals & Forecast

The Travere Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $6.10 and $6.60. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 28.33%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock

Travere Therapeutics, Inc. finds support from accumulated volume at $6.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.95 between high and low, or 14.09%. For the last week, the stock has had daily average volatility of 8.72%.

Since the Travere Therapeutics, Inc. has been rising for 7 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: $6.50 (-3.70%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (TVTX) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Travere Therapeutics, Inc. to open at $7.06, and during the day (based on 14 day Average True Range), to move between $6.30 and $7.20, which gives a possible trading interval of +/-$0.450 (+/-6.66%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.67 (1.19%) than the resistance at $7.49 (10.96%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Travere Therapeutics, Inc. stock A Buy?

Travere Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Travere Therapeutics, Inc. of Wednesday, May 8, 2024

Fair opening price May 8, 2024 Current price
$7.06 ( 4.59%) $6.75

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TVTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.01 18.67 %
R2 7.65 13.29 %
R1 7.42 9.97 %
Current price: 6.75
Support S1 6.70 -0.784 %
S2 6.47 -4.11 %
S3 6.11 -9.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.99 18.37 %
R2 7.88 16.74 %
R1 7.49 10.96 %
Current price 6.75
Support S1 6.67 -1.19%
S2 6.00 -11.11%
S3 5.39 -20.15%

FAQ

What is the symbol for Travere Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Travere Therapeutics, Inc. is TVTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Travere Therapeutics, Inc. Stock?
Travere Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Travere Therapeutics, Inc. Stock?
Travere Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Travere Therapeutics, Inc. Stock.

What's the current price of Travere Therapeutics, Inc. Stock?
As of the end of day on the May 07, 2024, the price of an Travere Therapeutics, Inc. (TVTX) share was $6.75.

What is the 52-week high and low for Travere Therapeutics, Inc. Stock?
The 52-week high for Travere Therapeutics, Inc. Stock is $21.45 and the 52-week low is $1.20.

What is the market capitalization of Travere Therapeutics, Inc. Stock?
As of the May 07, 2024, the market capitalization of Travere Therapeutics, Inc. is 498.445M.

When is the next earnings date for Travere Therapeutics, Inc.?
The upcoming earnings date for Travere Therapeutics, Inc. is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Travere Therapeutics, Inc.

Travere Therapeutics. Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzy... TVTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT